Table 1 Patient demographic and baseline characteristics

From: UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

 

2009 (n=25,069)

2010 (n=22,381)

 

SAR (n=18,341)

NSUAD (n=6,728)

SAR (n=16,187)

NSUAD (n=6,194)

Age, years mean (s.d.)

31.3 (20.1)

46.5 (22.1)

32.1 (20.3)

47.7 (21.9)

Male, n (%)

8,811 (48.0)

2,636 (39.2)

7,679 (47.4)

2,426 (39.2)

Recorded smoking status, n (%)

15,406 (84.0)

6,397 (95.1)

13,266 (82.0)

5,873 (94.8)

 Non-smokers

11,050 (71.7)

4,101 (64.1)

9,444 (71.2)

3,728 (63.5)

 Current smokers

1,889 (12.3)

707 (11.1)

1,637 (12.3)

644 (11.0)

 Ex-smokers

2,467 (16.0)

1,589 (24.8)

2,185 (16.5)

1,501 (25.5)

Asthma diagnosis, n (%)

7,145 (39.0)

3,745 (55.7)

5,517 (34.1)

3,270 (52.8)

Eczema diagnosis, n (%)

6,481 (35.3)

2,645 (39.3)

5,603 (34.6)

2,364 (38.2)

Urticaria, n (%)

1,621 (8.8)

809 (12.0)

1,553 (9.6)

596 (9.6)

Nasal polyps, n (%)

167 (0.9)

283 (4.2)

150 (0.9)

263 (4.2)

  1. Abbreviations: NSUAD, nonseasonal upper airways disease; SAR, seasonal allergic rhinitis.
Back to article page